2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
9485
Neoplasms
6599
Prostatic Neoplasms
4404
Colorectal Neoplasms
3979
Lung Neoplasms
3647
Carcinoma, Non-Small-Cell Lung
3587
Pancreatic Neoplasms
2480
Carcinoma, Hepatocellular
2416
Leukemia, Myeloid, Acute
2266
Multiple Myeloma
2123
Stomach Neoplasms
2109
Neoplasm Metastasis
1913
Head and Neck Neoplasms
1873
Ovarian Neoplasms
1778
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1734
Lymphoma
1731
Brain Neoplasms
1706
Rectal Neoplasms
1676
Melanoma
1657
Colonic Neoplasms
1629
Uterine Cervical Neoplasms
1501
Leukemia
1500
Recurrence
1486
Esophageal Neoplasms
1312
Glioblastoma
1310
Lymphoma, Non-Hodgkin
1205
Leukemia, Lymphocytic, Chronic, B-Cell
1120
Squamous Cell Carcinoma of Head and Neck
1109
Urinary Bladder Neoplasms
1080
Lymphoma, Follicular
1069
Interventions
pembrolizumab
1
osimertinib
1
binimetinib
1
Pemetrexed
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Non-small Cell Carcinoma
×
Clear all
NCT03991819
2025-12-05
BiniPembro
University Health Network, Toronto
Phase 1
Recruiting
40 enrolled
NCT04695925
2025-10-15
TOP
Sun Yat-sen University
Phase 3
Active not recruiting
294 enrolled